Search - tctmd.com

Displaying 181 - 200 of 651

Sort: Relevancy | Date

Presentation SCCT 2023

Intro to Structural Heart Disease – Valvular Heart Disease

Presenter: Tiffany Chen

July 28, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

Presentation TVT 2023

Challenging Percutaneous Treatment of Iatrogenic Pulmonary Stenosis with Stenting and Transcatheter Valve Implantation

Presenter: Wilton Gomes

June 09, 2023

Presentation TVT 2023

Severe Tricuspid Regurgitation with prior tricuspid ring, valve in ring followed by valve in valve and subsequent deployment of vascular plugs

Presenter: Muhammad Zulqarnain

June 09, 2023

Presentation TVT 2023

Treatment Of Severe Tricuspid Regurgitation Using a Heterotopic Cross-Caval Device

Presenter: Omar Abdul Jawad Altisent

June 09, 2023

Presentation TVT 2023

First in Man J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated with a Left Ventricular Assist Device

Presenter: Santiago Garcia

June 09, 2023

Presentation TVT 2023

Tricuspid Regurgitation Progression in Patients with Left-sided Valvular Heart Disease Correction

Presenter: Cheng Wang

June 08, 2023

News Conference News EHRA 2023

EPs Push for More Involvement in TAVI Heart Team Discussions

Michael O'Riordan

April 21, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Daily News

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Michael O'Riordan

March 16, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

SCAI Updates Position on Doing PCI Without Surgical Backup

Michael O'Riordan

February 20, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Todd Neale

January 06, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

Advertisement

Intro to Structural Heart Disease – Valvular Heart Disease

Women and Minorities Underrepresented in Heart Valve Trials

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Challenging Percutaneous Treatment of Iatrogenic Pulmonary Stenosis with Stenting and Transcatheter Valve Implantation

Severe Tricuspid Regurgitation with prior tricuspid ring, valve in ring followed by valve in valve and subsequent deployment of vascular plugs

Treatment Of Severe Tricuspid Regurgitation Using a Heterotopic Cross-Caval Device

First in Man J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated with a Left Ventricular Assist Device

Tricuspid Regurgitation Progression in Patients with Left-sided Valvular Heart Disease Correction

EPs Push for More Involvement in TAVI Heart Team Discussions

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

SCAI Updates Position on Doing PCI Without Surgical Backup

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Top Structural Heart News of 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content